Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 8
Submit an article Journal homepage
2,607
Views
10
CrossRef citations to date
0
Altmetric
Articles

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway

Midori KjellinDepartment of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden; View further author information
,
Hege KilengGastroenterology and Nutrition Research Group, Department of Clinical Medicine, UiT the Arctic University of Norway, Tromsø, Norway; ;Department of Medicine, University Hospital of North Norway, Tromsø, Norway; View further author information
,
Dario AkaberiDepartment of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden; View further author information
,
Navaneethan PalanisamyHBIGS, University of Heidelberg, Heidelberg, Germany; ;Institute of Biology II, University of Freiburg, Freiburg, Germany; ORCID Iconhttp://orcid.org/0000-0003-0369-2316View further author information
ORCID Icon,
Ann-Sofi DubergDepartment of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; View further author information
,
Astrid DanielssonDepartment of Infectious Diseases, Falun Hospital, Falun, Sweden; View further author information
,
Magnhild Gangsøy KristiansenNordlandssykehuset Bodø, Department of Clinical Medicine (IKM), UiT the Artic University of Tromsø, Tromsø, Norway; View further author information
,
Johan NöjdNordlandssykehuset Bodø, Department of Clinical Medicine (IKM), UiT the Artic University of Tromsø, Tromsø, Norway; View further author information
,
Soo AlemanDepartment of Infectious Diseases, Karolinska University Hospital/Karolinska Institutet, Stockholm, Sweden; View further author information
,
Tore GuttebergResearch Group for Host-Microbe Interactions, Department of Medical Biology, UiT the Arctic University of Norway, Tromsø, Norway; ;Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway; View further author information
,
Rasmus GollGastroenterology and Nutrition Research Group, Department of Clinical Medicine, UiT the Arctic University of Norway, Tromsø, Norway; ;Department of Medicine, University Hospital of North Norway, Tromsø, Norway; View further author information
,
Anders LannergårdDepartment of Medical Sciences, Section of Infectious Diseases, Uppsala University Hospital, Uppsala, SwedenView further author information
&
Johan LennerstrandDepartment of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden; Correspondence[email protected]
View further author information
 show all
Pages 1042-1050 | Received 14 May 2019, Accepted 31 Jul 2019, Published online: 19 Aug 2019

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ana Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, Marcilio Figueiredo Lemos, Fernanda de Mello Malta, Rúbia Anita Ferraz Santana, Gregório Tadeu Fernando Dastoli, Vanessa Fusco Duarte de Castro, João Renato Rebello Pinho & Regina Célia Moreira. (2021) Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil. Infection and Drug Resistance 14, pages 723-730.
Read now

Articles from other publishers (9)

Christina Sølund, Martin S. Pedersen, Ulrik Fahnøe, Jonathan Filskov, Håvard Jenssen, Nina Weis, Kristian Schønning & Jens Bukh. (2023) Pre‐existing, treatment‐specific resistance‐associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct‐acting antivirals . APMIS 131:8, pages 426-433.
Crossref
Sergii V. Fedorchenko, Tatiana Martynovych, Zhanna Klimenko & Iryna Solianyk. (2023) Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing NS5A inhibitors with sofosbuvir/velpatasvir plus ribavirin for 24 weeks. Journal of Clinical Virology Plus 3:2, pages 100150.
Crossref
Imran Shahid & Qaiser JabeenImran Shahid & Qaiser Jabeen. 2023. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives 231 289 .
Saima Mushtaq, Asraf Hussain Hashmi, Amjad Khan, Syed Muhammad Asad Raza Kazmi & Sobia Manzoor. (2022) Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals. Frontiers in Pharmacology 13.
Crossref
Ezequiel Ridruejo, Matías Javier Pereson, Diego M Flichman & Federico Alejandro Di Lello. (2021) Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions. World Journal of Hepatology 13:9, pages 1069-1078.
Crossref
Velia Chiara Di Maio, Silvia Barbaliscia, Elisabetta Teti, Gianluca Fiorentino, Martina Milana, Stefania Paolucci, Teresa Pollicino, Giulia Morsica, Mario Starace, Bianca Bruzzone, William Gennari, Valeria Micheli, Katia Yu La Rosa, Luca Foroghi, Vincenza Calvaruso, Ilaria Lenci, Ennio Polilli, Sergio Babudieri, Alessio Aghemo, Giovanni Raimondo, Loredana Sarmati, Nicola Coppola, Caterina Pasquazzi, Fausto Baldanti, Giustino Parruti, Carlo Federico Perno, Mario Angelico, Antonio Craxì, Massimo Andreoni, Francesca Ceccherini‐Silberstein, P Andreone, M Aragri, A Bertoli, E Boeri, G Brancaccio, M Brunetto, AP Callegaro, G Cenderello, V Cento, A Ciaccio, A Ciancio, N Cuomo, A De Santis, A Di Biagio, V Di Marco, G Di Perri, MA Di Stefano, GB Gaeta, V Ghisetti, R Gulminetti, P Lampertico, S Landonio, M Lichtner, A Lleo, I Maida, S Marenco, C Masetti, C Mastroianni, C Minichini, E Milano, L Monno, S Novati, V Pace Palitti, C Paternoster, A Pellicelli, A Pieri, M Puoti, G Rizzardini, T Ruggiero, B Rossetti, V Sangiovanni, T Santantonio, G Taliani, P Toniutto, V. Vullo & M Zazzi. (2021) Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C. Liver International 41:8, pages 1802-1814.
Crossref
Yong-yu Mei, You-ming Chen, Yuan-kai Wu, Xiao-hong Zhang & Wen-xiong Xu. (2020) Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection. Canadian Journal of Gastroenterology and Hepatology 2020, pages 1-8.
Crossref
Shan Ren, Feili Wei, Yi Jin, Junfeng Lu, Zhimin He, Lina Ma, Yanhong Zheng, Junli Wang & Xinyue Chen. (2019) Baseline Resistance-Associated Substitutions may Impact DAA Response among Treatment Failure Chronic Hepatitis C Patients with Pegylated Interferon and Ribavirin in Real Life. Antiviral Therapy 25:5, pages 245-255.
Crossref
Juan Li, Dong-Bo Wu, Wei Jiang, Xue-Bin Chen, Gui-Bao Xiao, Yong-Hong Wang, Meng-Lan Wang, Ya-Chao Tao & En-Qiang Chen. (2020) Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination. Medicine 99:43, pages e22726.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.